Skip to main content

A Start-Up Claimed Its Device Could Cure Cancer. Then Patients Began Dying.

A Start-Up Claimed Its Device Could Cure Cancer. Then Patients Began Dying.
By John Carreyrou from NYT Business Day https://ift.tt/a8T0WXb
Cancer, Regulation and Deregulation of Industry, Blood, Food and Drug Administration, Antigua and Barbuda, Florida, Medical Devices, Tumors, Heparin (Drug), Deaths (Fatalities)
Labels:

Comments

Post a Comment

Popular posts from this blog

Practical Approaches to Long-Term Cloud-Native Security

There is no shortage of advice out there about how to secure modern, cloud-native workloads. By now, most developers and IT engineers who work with cloud-native deployments have heard all of the mantras about DevSecOps, shift-left security, multi-layer defenses and dynamic baselining (to name just some of the key concepts that are driving IT security […] The post Practical Approaches to Long-Term Cloud-Native Security appeared first on DevOps.com . from DevOps.com https://ift.tt/2PggVhj
Post a Comment
Read more

OpenAPI Specification: Perception vs. Reality

The OpenAPI Specification (OAS) (formerly known as the Swagger specification) provides a way to describe and document REST APIs and their components. It includes details on endpoints, their operations, parameters needed for the operations, expected responses for every operation, authentication methods and even annotations. OAS is an easy format to learn and read, and can […] The post OpenAPI Specification: Perception vs. Reality appeared first on DevOps.com . from DevOps.com https://ift.tt/3tsqvBh
Post a Comment
Read more